2015Unpublished venueRequires access

Relationship between PI3K Mutation and Sodium-Iodide Symporter in Anaplastic Thyroid Carcinoma

Farzaneh Bozorg-Ghalati, Mehdi Hedayati

Open publisher page 3 citations

Abstract

The sodium-iodide symporter is a transmembrane protein that has important role in radio-iodide therapy in various cancers such as anaplastic thyroid carcinoma. Anaplastic thyroid carcinoma is a rare undifferentiated thyroid tumor, but highly aggressive and lethal malignancy. Usually it is resistant to radio-iodide therapy and a cause of this appearance knows through dysfunction of the sodium-iodide symporter. Some genomic mutations, like PI3K gene mutations, can affect on sodium-iodide symporter functions. This review article explains briefly about PI3K signaling pathway and survey its gene mutations in carcinomas especially in anaplastic thyroid carcinoma and its influence on sodium-iodide symporter and iodide uptake.

About this research paper

What this paper is about

The sodium-iodide symporter is a transmembrane protein that has important role in radio-iodide therapy in various cancers such as anaplastic thyroid carcinoma. Anaplastic thyroid carcinoma is a rare undifferentiated thyroid tumor, but highly aggressive and lethal malignancy. Usually it is resistant to radio-iodide therapy and a cause of this appearance knows through dysfunction of the sodium-iodide symporter. Some genomic mutations, like PI3K gene mutations, can affect on sodium-iodide symporter functions. This review article explains briefly about PI3K signaling pathway and survey its gene mutations in carcinomas especially in anaplastic thyroid carcinoma and its influence on sodium-iodide symporter and iodide uptake.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The sodium-iodide symporter is a transmembrane protein that has important role in radio-iodide therapy in various cancers such as anaplastic thyroid carcinoma. Anaplastic thyroid carcinoma is a rare undifferentiated thyroid tumor, but highly aggressive and lethal malignancy. Usually it is resistant to radio-iodide therapy and a cause of this appearance knows through dysfunction of the sodium-iodide symporter. Some genomic mutations, like PI3K gene mutations, can affect on sodium-iodide symporter functions. This review article explains briefly about PI3K signaling pathway and survey its gene mutations in carcinomas especially in anaplastic thyroid carcinoma and its influence on sodium-iodide symporter and iodide uptake.

Key concepts: Sodium-iodide symporter, Symporter, Cancer research, Anaplastic thyroid cancer, Thyroid carcinoma, Thyroid, Sodium iodide, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Relationship between PI3K Mutation and Sodium-Iodide Symporter in Anaplastic Thyroid Carcinoma — Research Paper | ScholarLens